Home › Cancer (all types)
Cancer (all types) clinical trials recruiting in the U.S.
615 studies for Cancer (all types) are recruiting participants at sites across the United States.
If you or someone you love has been diagnosed with cancer, learn about diagnosis, treatment, risk factors, coping and much more.
Cities with the most studies
- Houston, TX124 studies
- New York City, NY105 studies
- Boston, MA90 studies
- Los Angeles, CA73 studies
- Nashville, TN65 studies
- Durham, NC61 studies
- Washington, DC60 studies
- Philadelphia, PA57 studies
- Arlington, VA52 studies
- Chicago, IL51 studies
- St. Louis, MO51 studies
- Atlanta, GA49 studies
- Seattle, WA48 studies
- Pittsburgh, PA42 studies
- San Antonio, TX41 studies
- Columbus, OH40 studies
- Dallas, TX40 studies
- San Francisco, CA38 studies
- Mountain View, CA38 studies
- Tampa, FL38 studies
- Portland, OR36 studies
- Cleveland, OH36 studies
- Baltimore, MD36 studies
- Miami, FL36 studies
- New Haven, CT35 studies
- Baldwin Park, CA34 studies
- Aurora, CO34 studies
- Edison, NJ33 studies
- San Diego, CA31 studies
- Rochester, MN31 studies
- Memphis, TN30 studies
- Birmingham, AL30 studies
- Jacksonville, FL29 studies
- Charlotte, NC29 studies
- Detroit, MI27 studies
- Grand Rapids, MI27 studies
- Cincinnati, OH26 studies
- Ann Arbor, MI25 studies
- Queens, NY25 studies
- Salt Lake City, UT25 studies
By state
- Alabama35 studies
- Alaska3 studies
- Arizona53 studies
- Arkansas23 studies
- California172 studies
- Colorado53 studies
- Connecticut46 studies
- Delaware9 studies
- District of Columbia26 studies
- Florida127 studies
- Georgia64 studies
- Hawaii13 studies
- Idaho4 studies
- Illinois68 studies
- Indiana30 studies
- Iowa19 studies
- Kansas18 studies
- Kentucky27 studies
- Louisiana17 studies
- Maine6 studies
- Maryland68 studies
- Massachusetts100 studies
- Michigan73 studies
- Minnesota50 studies
- Mississippi9 studies
- Missouri62 studies
- Nebraska23 studies
- Nevada14 studies
- New Hampshire12 studies
- New Jersey61 studies
- New Mexico16 studies
- New York138 studies
- North Carolina92 studies
- North Dakota11 studies
- Ohio85 studies
- Oklahoma16 studies
- Oregon43 studies
- Pennsylvania100 studies
- Rhode Island12 studies
- South Carolina30 studies
- South Dakota12 studies
- Tennessee91 studies
- Texas185 studies
- Utah38 studies
- Vermont6 studies
- Virginia77 studies
- Washington57 studies
- West Virginia7 studies
- Wisconsin42 studies
Recently updated studies
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RecruitingPhase 3
Ages 18 to 100 · All sexes · Updated Nov 13, 2026 · NCT05920356Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance
RecruitingPhase 2
Ages 18 to 120 · Men · Updated Nov 13, 2026 · NCT07574541Bexmarilimab + Azacitidine Versus Placebo + Azacitidine in Participants With Treatment-naïve Higher-risk Myelodysplastic Syndromes
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT07672769A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 13, 2026 · NCT06818643Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 2 and older · All sexes · Updated Nov 12, 2026 · NCT00033137Feasibility Pilot of AYA-PARTNER
Recruiting
Ages 18 to 39 · All sexes · Updated Nov 12, 2026 · NCT07829146Clinical and Genetic Studies of Li-Fraumeni Syndrome
RecruitingObservational studyHealthy volunteers welcome
All ages · All sexes · Updated Nov 12, 2026 · NCT01443468Post-Marketing Study for Early-Stage Low-Risk Breast Cancer Treatment Using ProSense® Cryoablation (ChoICE Trial)
Recruiting
Ages 70 and older · All sexes · Updated Nov 12, 2026 · NCT07629206000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
RecruitingPhase 1/2
Ages 15 to 99 · All sexes · Updated Nov 12, 2026 · NCT05588141Medically Tailored Meals to Improve Cancer Outcomes
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07924241Evaluation for NCI Surgery Branch Clinical Research Protocols
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT00001823Multicenter Study for External Validation of the TB-NET Score
RecruitingObservational study
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07903532A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
RecruitingPhase 1
Ages 16 and older · All sexes · Updated Nov 12, 2026 · NCT07197554Effects of Latin Dancing on Sleep Quality in Hispanic Cancer Survivors
Recruiting
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT06844981A Study of YL242 in Subjects With Advanced Solid Tumors
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Nov 12, 2026 · NCT07197827Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT06423950Childhood Cancer Predisposition Study (CCPS)
RecruitingObservational study
All ages · All sexes · Updated Nov 12, 2026 · NCT04511806Tumor Related Epilepsy
RecruitingObservational study
Ages 8 to 99 · All sexes · Updated Nov 12, 2026 · NCT02639325KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07252739A Study of Belzutifan in Adolescent Participants With Solid Tumors (MK-9999-01E/LIGHTBEAM-U01)
RecruitingPhase 2
Ages 12 to 17 · All sexes · Updated Nov 10, 2026 · NCT07700758BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT07869836A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Nov 10, 2026 · NCT05650632RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Nov 10, 2026 · NCT07002034Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT06580314Collection of Blood From Patients With Cancer
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Nov 9, 2026 · NCT00034216From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.